FP
Fennec Pharmaceuticals Inc
🇩🇪XFRA.RV41GermanyHealthcare
€9.10EURdown -0.15 (-1.62%)ClosedEnd of day10:14 PM
Price€9.10-0.15 (-1.62%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- CA31447P1009
- CUSIP
- Not reported
Company
- Employees
- 35
- Headquarters
- Research Triangle Park, United States
- Website
- https://www.fennecpharma.com
- CEO
- Mr. Jeffrey S. Hackman
Market
- Shares outstanding
- 35.1M
- Market cap
- €319.11M
Key dates
- Next earnings
- Nov 12, 2026
Highlights
- Market cap
- €319.11M
- EPS LTM
- -$0.09calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $59.22M+77.83%up year on year
- Net income
- -$3.25M+72.99%up year on year
- Gross margin
- 93.73%+4.27%up year on year
- Free cash flow
- -$2.04M+82.54%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.